Small animal 3T PET/MR scanner

PET/MR小动物成像对于未来的研究理念和建立跨学科重点的放射性药物开发平台至关重要。这个概念基本上是基于生物技术过程的创新使用，作为生物化学、化学、生物技术、医学和药学等研究领域的跨学科互动。放射性药物科学领域的这些项目位于一个多功能和临床导向的科学环境中，包括示踪剂开发以及对新的放射性药物进行有效和量身定制的临床前评估。应用合适的生物学方法，通过现代多模态小动物成像（PET/MR）来表征体内药代动力学特性，对于可靠地鉴定具有临床潜力的新型放射性药物至关重要。这些项目密切关注临床和科学环境的需要，并将开辟新的转化关键方面和方法。放射性药物将针对新的表面受体和肿瘤微环境的特定成分产生，用于肿瘤分期和转移特异性事件的现代分子成像。PET/MR小动物成像对于这些分子过程的可视化以及创新性心脏病学项目和神经退行性疾病的研究至关重要。

PET/MR small animal imaging is of crucial importance for the future research concept and the establishment of a development platform for radiopharmaceuticals with an interdisciplinary focus. The concept is essentially based on the innovative use of biotechnological processes as an interdisciplinary interaction of the research fields of biochemistry, chemistry, biotechnology, medicine and pharmacy. These projects in the field of radiopharmaceutical science are located within a versatile and clinically oriented scientific environment and include tracer development as well as efficient and tailor-made preclinical evaluation of new radiopharmaceuticals. The application of suitable biological methods for the characterization of in vivo pharmacokinetic properties via modern multimodal small animal imaging (PET/MR) is essential for the reliable identification of new radiopharmaceuticals with clinical potential. The projects are closely oriented to the needs of the clinical and scientific environment and will open up new translational key aspects and approaches. Radiopharmaceuticals will be generated against new surface receptors and specific components of the tumor microenvironment for modern molecular imaging of tumor stages and metastasis-specific events. PET/MR small animal imaging is essential for the visualization of these molecular processes as well as for innovative cardiological projects and research on neurodegenerative diseases.